![](/img/cover-not-exists.png)
B1*CORE-URO-01 study: comparison of safety and efficacy of pazopanib in first-line metastatic renal cell carcinoma (mRCC) with or without renal failure
Masini, C, Vitale, M G, Maruzzo, M, Procopio, G, De Giorgi, U, Buti, S, Rossetti, S, Iacovelli, R, Guida, A, Atzori, F, Mucciarini, C, Cosmai, L, Vignani, F, Prati, G, Scagliarini, S, Berselli, A, PinVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx423
Date:
October, 2017
File:
PDF, 73 KB
english, 2017